Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)
Yutaka Kokubo(Nippon Medical School), Shoji Kudoh(Japan Anti Tuberculosis Association)
Cited by 135
Related Papers
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2005|953
Interstitial Lung Disease in Japanese Patients with Lung Cancer
|American Journal of Respiratory and Critical Care Medicine|2008|488
Serological Diagnosis of Idiopathic Pulmonary Alveolar Proteinosis
|American Journal of Respiratory and Critical Care Medicine|2000|226
PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors
|International Journal of Oncology|2007|53